OGXI


Company Update (NASDAQ:OGXI): Here’s Why OncoGenex Pharmaceuticals Inc Shares Jumped 30% Today

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) investors cheer the news that drug maker achieved positive survival results from its final analysis of the Phase 2 Borealis-2™ trial …

Analysts Weigh In On Two Collapsing Biotechs: Zafgen Inc (ZFGN), OncoGenex Pharmaceuticals Inc (OGXI)

Analysts are weighing in on the biopharmaceutical companies Zafgen Inc (NASDAQ:ZFGN) and OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), as shares of both companies fell sharply today due …

Looking Ahead in Biotech: Ariad Pharmaceuticals, Inc. (ARIA), Dynavax Technologies Corporation (DVAX), OncoGenex Pharmaceuticals Inc (OGXI)

Biotechnology companies release data on pipeline drug studies up update analysts and investors on the progress of a drug. Positive data releases have …

UPDATE: William Blair Cuts Oncogenex Price Target By Half As Teva Returns Custirsen Rights

In a research report released today, William Blair analyst Y Katherine Xu maintained an Outperform rating on Oncogenex (NASDAQ:OGXI), but reduced her price target …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts